Jenburkt Pharmaceuticals Limited (BOM:524731)
India
· Delayed Price · Currency is INR 1,086.20
+36.40 (3.47%)
At close: May 16, 2025
Jenburkt Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | 259.77 | 246.07 | 222.97 | 165.02 | 148.7 | Upgrade
|
| Depreciation & Amortization | 20.63 | 21.28 | 17 | 16.63 | 17.66 | Upgrade
|
| Other Amortization | 2.77 | 1.31 | 1.98 | 3.73 | 5.33 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.19 | 0.49 | -0.33 | -0.02 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.33 | -0.04 | -0.02 | -0.01 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 12.88 | 5.93 | 0.84 | 1.92 | - | Upgrade
|
| Other Operating Activities | -31.5 | -44.02 | -41.82 | -45.23 | -27.2 | Upgrade
|
| Change in Accounts Receivable | -36.86 | -15.87 | -10.45 | 36.37 | 50.65 | Upgrade
|
| Change in Inventory | -2.24 | 15.5 | -23.06 | 33.17 | -10.68 | Upgrade
|
| Change in Accounts Payable | 1.6 | -10.14 | 25.18 | -16.14 | -13.23 | Upgrade
|
| Change in Other Net Operating Assets | -144.68 | -49.99 | -99.57 | -0.89 | -21.07 | Upgrade
|
| Operating Cash Flow | 81.24 | 170.52 | 92.71 | 194.55 | 150.17 | Upgrade
|
| Operating Cash Flow Growth | -52.36% | 83.92% | -52.34% | 29.55% | 15.63% | Upgrade
|
| Capital Expenditures | -25.54 | -21.05 | -30.54 | -11.45 | -45.54 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | 5.06 | 0.3 | 9.91 | Upgrade
|
| Investment in Securities | -35.54 | 31.84 | -37.3 | -214.78 | -15.61 | Upgrade
|
| Other Investing Activities | 55.27 | 15.38 | 50.75 | 38.12 | 22.48 | Upgrade
|
| Investing Cash Flow | -5.8 | 26.18 | -12.02 | -187.81 | -28.76 | Upgrade
|
| Long-Term Debt Repaid | -5.1 | -5.1 | -5.1 | -5.1 | - | Upgrade
|
| Net Debt Issued (Repaid) | -5.1 | -5.1 | -5.1 | -5.1 | - | Upgrade
|
| Repurchase of Common Stock | - | -145.15 | - | - | - | Upgrade
|
| Common Dividends Paid | -63.18 | -55 | -46.8 | - | -85.82 | Upgrade
|
| Other Financing Activities | -2.5 | -5.17 | -3.41 | -2.04 | -22.52 | Upgrade
|
| Financing Cash Flow | -70.78 | -210.41 | -55.31 | -7.14 | -108.34 | Upgrade
|
| Net Cash Flow | 4.66 | -13.71 | 25.38 | -0.4 | 13.07 | Upgrade
|
| Free Cash Flow | 55.7 | 149.48 | 62.17 | 183.1 | 104.62 | Upgrade
|
| Free Cash Flow Growth | -62.74% | 140.43% | -66.05% | 75.00% | -1.16% | Upgrade
|
| Free Cash Flow Margin | 3.92% | 10.93% | 5.01% | 16.75% | 8.80% | Upgrade
|
| Free Cash Flow Per Share | 12.62 | 32.74 | 13.55 | 39.90 | 22.80 | Upgrade
|
| Cash Interest Paid | 2.5 | 5.16 | 3.41 | 3.48 | 4.94 | Upgrade
|
| Cash Income Tax Paid | 82.63 | 82.24 | 75.61 | 58.37 | 71.91 | Upgrade
|
| Levered Free Cash Flow | 182.73 | 131.18 | 143.35 | 166.54 | 115.24 | Upgrade
|
| Unlevered Free Cash Flow | 184.17 | 133.05 | 145.52 | 169.19 | 118.33 | Upgrade
|
| Change in Net Working Capital | 6.08 | 44.67 | 1.9 | -48.98 | -31.84 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.